Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA

被引：9

作者：

Nindita, Yora ^{[2
,3
]}

Hamada, Toshihiro ^{[1
]}

Bahrudin, Udin ^{[2
,4
]}

Hosoyamada, Makoto ^{[5
]}

Ichida, Kimiyoshi ^{[6
]}

Iwai, Chisato ^{[2
]}

Urashima, Sunao ^{[2
]}

Kuwabara, Narimasa ^{[2
]}

Utami, Sulistiyati Bayu ^{[2
]}

Mizuta, Einosuke

Yamada, Kensaku

Igawa, Osamu

Shigemasa, Chiaki

Ninomiya, Haruaki ^{[7
]}

Tsuchihashi, Takuya ^{[8
]}

Hisatome, Ichiro ^{[2
]}

机构：

[1] Tottori Univ, Div Cardiovasc Med, Fac Med, Dept Cardiovasc Med, Yonago, Tottori 6838504, Japan

[2] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut,Dept Genet Med & Re, Yonago, Tottori 6838504, Japan

[3] Diponegoro Univ, Fac Med, Dept Pharmacol & Therapeut, Semarang, Indonesia

[4] Diponegoro Univ, Fac Med, Dept Cardiol & Vasc Med, Semarang, Indonesia

[5] Kyoritsy Univ Pharm, Dept Pharmacotherapeut, Tokyo, Japan

[6] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo, Japan

[7] Tottori Univ, Dept Regulat Biol, Fac Med, Yonago, Tottori 6838504, Japan

[8] Natl Kyushu Med Ctr, Clin Res Ctr, Div Hypertens, Fukuoka, Japan

来源：

ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2010年 / 60卷 / 04期

关键词：

Benzbromarone; CAS; 3562-84-3; 124750-99-8; Human urate transporter 1 mRNA; Losartan; II RECEPTOR ANTAGONIST; BRUSH-BORDER MEMBRANE; URIC-ACID; HEALTHY-SUBJECTS; HYPERTENSION; METABOLISM;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Both an angiotensin II receptor blocker, losartan (CAS 124750-99-8) and a serum urate lowering agent, benzbromarone (CAS 3562-84-3) exert a uricosuric action by inhibiting urate transporter 1 (URAT1). A recent clinical trial indicated that losartan could reduce the level of serum urate in hypertensive patients treated with urate lowering agents, suggesting the different mode of action of losartan from benzbromarone. In the present study, the effect of losartan and benzbromarone on the level of URAT1 mRNA was determined in transfected HEK293 cells. Losartan caused a significant reduction of its mRNA level, whereas it was not affected by benzbromarone. These results indicate that losartan decreases the level of human URAT1 mRNA, which may underlie the uricosuric action of losartan in hypertensive patients treated with serum urate lowering agents.

引用

页码：186 / 188

页数：3

共 50 条

[1] Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients
Hamada, T.
Mizuta, E.
Kaetsu, Y.
Sugibara, S.
Yanagihara, K.
Yamamoto, Y.
Kato, M.
Igawa, O.
Shigemasa, C.
Hisatome, I.
JOURNAL OF HYPERTENSION, 2008, 26 : S28 - S28
[2] Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients
Hamada, Toshihiro
Ichica, Kimiyoshi
Hosoyamada, Makoto
Mizuta, Einosuke
Yanagihara, Kiyotaka
Sonoyama, Kazuhiko
Sugihara, Shinobu
Igawa, Osamu
Hosoya, Tatsuo
Ohtahara, Akira
Shigamasa, Chiaki
Yamamoto, Yasutaka
Ninomiya, Haruaki
Hisatome, Ichiro
AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (10) : 1157 - 1162
[3] Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1
Uetake, Daijiro
Ohno, Iwao
Ichida, Kimiyoshi
Yamaguchi, Yuichiro
Saikawa, Hajime
Endou, Hitoshi
Hosoya, Tatsuo
INTERNAL MEDICINE, 2010, 49 (02) : 89 - 94
[4] Human urate transporter 1 (hURAT1) mediates the transport of orotate
Miura, Daisaku
Anzai, Naohiko
Jutabha, Promsuk
Chanluang, Suparat
He, Xin
Fukutomi, Toshiyuki
Endou, Hitoshi
JOURNAL OF PHYSIOLOGICAL SCIENCES, 2011, 61 (03): : 253 - 257
[5] Human urate transporter 1 (hURAT1) mediates the transport of orotate
Daisaku Miura
Naohiko Anzai
Promsuk Jutabha
Suparat Chanluang
Xin He
Toshiyuki Fukutomi
Hitoshi Endou
The Journal of Physiological Sciences, 2011, 61 : 253 - 257
[6] Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes
Zhang, Bingqing
Duan, Mengyuan
Long, Bo
Zhang, Baozhong
Wang, Dongmei
Zhang, Yun
Chen, Jialin
Huang, Xiaoming
Jiao, Yang
Zhu, Lei
Zeng, Xuejun
MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1645 - 1654
[7] Identification and characterization of a potent and selective inhibitor of human urate transporter 1
Ting Wu
Jiasheng Chen
Shuai Dong
Haixin Li
Ying Cao
Yuanxin Tian
Weimin Fu
Pingzheng Zhou
Baomin Xi
Jianxin Pang
Pharmacological Reports, 2017, 69 : 1103 - 1112
[8] Structural basis for the transport and substrate selection of human urate transporter 1
He, Jingjing
Liu, Guoyun
Kong, Fang
Tan, Qiulong
Wang, Zhenzhou
Yang, Meng
He, Yonglin
Jia, Xiaoxiao
Yan, Chuangye
Wang, Chao
Qian, Hongwu
CELL REPORTS, 2024, 43 (08):
[9] Identification and characterization of a potent and selective inhibitor of human urate transporter 1
Wu, Ting
Chen, Jiasheng
Dong, Shuai
Li, Haixin
Cao, Ying
Tian, Yuanxin
Fu, Weimin
Zhou, Pingzheng
Xi, Baomin
Pang, Jianxin
PHARMACOLOGICAL REPORTS, 2017, 69 (05) : 1103 - 1112
[10] Human urate transporter 1 (URAT1) mediates the transport of orotic acid
Miura, Daisaku
Anzai, Naohiko
Tsukada, Ai
Kimura, Toru
Fukutomi, Toshiyuki
Kiyomiya, Ken-ichi
Sakurai, Hiroyuki
Endou, Hitoshi
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 134P - 134P

← 1 2 3 4 5 →